FibroGen, Inc. (FGEN)
USD 0.33
(-1.56%)
USD 0.33
(-1.56%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -284.23 Million USD | 3.72% |
| 2022 | -295.22 Million USD | -1.44% |
| 2021 | -291.03 Million USD | -53.75% |
| 2020 | -189.29 Million USD | -145.93% |
| 2019 | -76.97 Million USD | 10.93% |
| 2018 | -86.42 Million USD | 31.52% |
| 2017 | -126.2 Million USD | -104.61% |
| 2016 | -61.68 Million USD | 28.09% |
| 2015 | -85.77 Million USD | -44.16% |
| 2014 | -59.5 Million USD | -298.21% |
| 2013 | -14.94 Million USD | 54.12% |
| 2012 | -32.57 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -32.93 Million USD | 41.43% |
| 2024 Q2 | -15.54 Million USD | 52.8% |
| 2023 Q3 | -63.61 Million USD | 27.45% |
| 2023 Q4 | -56.23 Million USD | 11.61% |
| 2023 FY | -284.23 Million USD | 3.72% |
| 2023 Q1 | -77.5 Million USD | -16.62% |
| 2023 Q2 | -87.68 Million USD | -13.13% |
| 2022 Q4 | -66.45 Million USD | 27.49% |
| 2022 Q3 | -91.65 Million USD | -25.22% |
| 2022 Q2 | -73.18 Million USD | -15.21% |
| 2022 Q1 | -63.52 Million USD | 52.62% |
| 2022 FY | -295.22 Million USD | -1.44% |
| 2021 Q2 | -133.98 Million USD | -86.73% |
| 2021 Q3 | 49.79 Million USD | 137.17% |
| 2021 Q4 | -134.07 Million USD | -369.25% |
| 2021 FY | -291.03 Million USD | -53.75% |
| 2021 Q1 | -71.75 Million USD | -22.38% |
| 2020 Q2 | -85.31 Million USD | -8.89% |
| 2020 Q3 | 33 Million USD | 138.69% |
| 2020 Q4 | -58.63 Million USD | -277.66% |
| 2020 FY | -189.29 Million USD | -145.93% |
| 2020 Q1 | -78.34 Million USD | 20.15% |
| 2019 Q1 | -45.41 Million USD | -316.73% |
| 2019 FY | -76.97 Million USD | 10.93% |
| 2019 Q4 | -98.12 Million USD | -98.47% |
| 2019 Q3 | -49.43 Million USD | -142.62% |
| 2019 Q2 | 116 Million USD | 355.45% |
| 2018 Q1 | -41.39 Million USD | -87.13% |
| 2018 Q2 | -23.42 Million USD | 43.42% |
| 2018 FY | -86.42 Million USD | 31.52% |
| 2018 Q4 | 20.95 Million USD | 149.24% |
| 2018 Q3 | -42.55 Million USD | -81.71% |
| 2017 Q4 | -22.12 Million USD | 41.38% |
| 2017 FY | -126.2 Million USD | -104.61% |
| 2017 Q1 | -33.16 Million USD | 2.47% |
| 2017 Q2 | -33.18 Million USD | -0.07% |
| 2017 Q3 | -37.73 Million USD | -13.72% |
| 2016 Q3 | -24.15 Million USD | -199.33% |
| 2016 FY | -61.68 Million USD | 28.09% |
| 2016 Q4 | -34 Million USD | -40.77% |
| 2016 Q1 | -27.84 Million USD | 45.8% |
| 2016 Q2 | 24.31 Million USD | 187.34% |
| 2015 Q2 | 57.05 Million USD | 223.05% |
| 2015 Q1 | -46.36 Million USD | 8.29% |
| 2015 FY | -85.77 Million USD | -44.16% |
| 2015 Q4 | -51.36 Million USD | -13.91% |
| 2015 Q3 | -45.09 Million USD | -179.04% |
| 2014 Q4 | -50.56 Million USD | -27.89% |
| 2014 Q3 | -39.53 Million USD | -184.42% |
| 2014 Q1 | -16.24 Million USD | 39.34% |
| 2014 Q2 | 46.83 Million USD | 388.37% |
| 2014 FY | -59.5 Million USD | -298.21% |
| 2013 FY | -14.94 Million USD | 54.12% |
| 2013 Q4 | -26.77 Million USD | -168.12% |
| 2013 Q3 | 39.3 Million USD | 522.75% |
| 2013 Q2 | -9.29 Million USD | 48.85% |
| 2013 Q1 | -18.17 Million USD | 0.0% |
| 2012 FY | -32.57 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Absci Corporation | -110.56 Million USD | -157.07% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -26.185% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 35.437% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2757.25% |
| Apollomics, Inc. | -172.6 Million USD | -64.676% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1325.786% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -844.481% |
| Bicycle Therapeutics plc | -180.66 Million USD | -57.326% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -287.517% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -58.742% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -955.134% |
| Chimerix, Inc. | -82.09 Million USD | -246.223% |
| CRISPR Therapeutics AG | -153.61 Million USD | -85.035% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1351.021% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -301.486% |
| Fortress Biotech, Inc. | -60.63 Million USD | -368.744% |
| Fortress Biotech, Inc. | -60.63 Million USD | -368.744% |
| Gritstone bio, Inc. | -138.49 Million USD | -105.236% |
| Allakos Inc. | -185.7 Million USD | -53.059% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -474.973% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -139.832% |
| Cytokinetics, Incorporated | -526.24 Million USD | 45.989% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -184.468% |
| Innoviva, Inc. | 179.72 Million USD | 258.151% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3522.917% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2235.124% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -143.353% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2266016.758% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -215.078% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -243.948% |
| ImmuCell Corporation | -5.77 Million USD | -4822.109% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -151.62% |
| Incyte Corporation | 597.59 Million USD | 147.562% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -110.359% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4164.611% |
| Mustang Bio, Inc. | -51.6 Million USD | -450.816% |
| MiMedx Group, Inc. | 67.43 Million USD | 521.465% |
| MEI Pharma, Inc. | 17.77 Million USD | 1698.785% |
| MacroGenics, Inc. | -9.05 Million USD | -3037.911% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -3282.83% |
| Mereo BioPharma Group plc | -29.46 Million USD | -864.61% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1923.595% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -101.006% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -138.792% |
| Minerva Neurosciences, Inc. | -30 Million USD | -847.271% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2179.326% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2712.229% |
| NextCure, Inc. | -62.72 Million USD | -353.154% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -478.648% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2746.305% |
| Onconetix, Inc. | -37.4 Million USD | -659.782% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -619.957% |
| Opthea Limited | -220.24 Million USD | -29.054% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -443.06% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -455.585% |
| PDS Biotechnology Corporation | -42.94 Million USD | -561.894% |
| Precigen, Inc. | -95.9 Million USD | -196.371% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1058.098% |
| Prime Medicine, Inc. | -198.13 Million USD | -43.455% |
| PureTech Health plc | -65.69 Million USD | -332.641% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -15.732% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 107.189% |
| Replimune Group, Inc. | -215.79 Million USD | -31.715% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -236259.705% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1032.805% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1432.571% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 34.864% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1067.791% |
| Sesen Bio, Inc. | -19.88 Million USD | -1329.451% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -10.24% |
| Solid Biosciences Inc. | -96.01 Million USD | -196.029% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -35.762% |
| SciSparc Ltd. | -5.12 Million USD | -5449.239% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -166.152% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2342.992% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -143.646% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -5003.825% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -155.148% |
| UroGen Pharma Ltd. | -102.24 Million USD | -177.994% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -324.259% |
| XOMA Corporation | -40.83 Million USD | -596.118% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 2.724% |
| AbCellera Biologics Inc. | -146.39 Million USD | -94.15% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -422.274% |
| Cassava Sciences, Inc. | -97.21 Million USD | -192.369% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -537.244% |
| Precision BioSciences, Inc. | -61.31 Million USD | -363.53% |
| Dyadic International, Inc. | -6.79 Million USD | -4082.674% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2597.21% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -30266.667% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -898.988% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -129.064% |
| IGM Biosciences, Inc. | -246.41 Million USD | -15.346% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -180.953% |
| Acelyrin, Inc. | -381.64 Million USD | 25.524% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -424.529% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 644.986% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1393.687% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -856.205% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -72.708% |
| Senti Biosciences, Inc. | -92.91 Million USD | -205.892% |
| Mesoblast Limited | -87.95 Million USD | -223.152% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -93.405% |
| ChromaDex Corporation | -4.93 Million USD | -5656.015% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5832.047% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -447.39% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3546.482% |
| Seer, Inc. | -86.27 Million USD | -229.441% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -356.561% |
| Novavax, Inc. | -545.06 Million USD | 47.853% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1771.239% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -76.621% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -448.213% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -21.139% |
| Celcuity Inc. | -63.77 Million USD | -345.651% |
| ContextLogic Inc. | -317 Million USD | 10.337% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -40.994% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -248.409% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 168.517% |
| Amarin Corporation plc | -59.11 Million USD | -380.836% |
| AnaptysBio, Inc. | -163.61 Million USD | -73.716% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1532.485% |
| Aptorum Group Limited | -2.82 Million USD | -9962.567% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -29.367% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -38.464% |
| Ardelyx, Inc. | -66.06 Million USD | -330.218% |
| Celularity Inc. | -196.29 Million USD | -44.798% |
| Omeros Corporation | -117.81 Million USD | -141.257% |
| Humacyte, Inc. | -110.77 Million USD | -156.583% |
| Immunocore Holdings plc | -55.28 Million USD | -414.103% |
| IO Biotech, Inc. | -86.08 Million USD | -230.184% |
| GT Biopharma, Inc. | -7.59 Million USD | -3641.372% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -319.996% |
| Summit Therapeutics Inc. | -614.92 Million USD | 53.778% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -708.856% |
| Pulmatrix, Inc. | -14.12 Million USD | -1912.832% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 40.932% |
| Evogene Ltd. | -23.87 Million USD | -1090.301% |
| CorMedix Inc. | -46.33 Million USD | -513.372% |
| BioLineRx Ltd. | -60.61 Million USD | -368.921% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -868.027% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -919.63% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 54.639% |
| scPharmaceuticals Inc. | -54.81 Million USD | -418.577% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -192.014% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 367.79% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2235.124% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1067.791% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -87.292% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -709.34% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1263.877% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -171.475% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -267.282% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -381.891% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1523.613% |
| Daré Bioscience, Inc. | -30.16 Million USD | -842.37% |
| bluebird bio, Inc. | -211.91 Million USD | -34.127% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 269.544% |
| DBV Technologies S.A. | -72.72 Million USD | -290.826% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -33.933% |
| Galecto, Inc. | -38.34 Million USD | -641.172% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -733.5% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -493.151% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -17.762% |
| GlycoMimetics, Inc. | -36.89 Million USD | -670.289% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -8.428% |
| ADMA Biologics, Inc. | -28.23 Million USD | -906.523% |
| Clene Inc. | -49.5 Million USD | -474.16% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 13.361% |
| Aptose Biosciences Inc. | -51.2 Million USD | -455.065% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -189.154% |
| Soligenix, Inc. | -6.14 Million USD | -4528.635% |
| Century Therapeutics, Inc. | -136.67 Million USD | -107.965% |
| Kura Oncology, Inc. | -152.63 Million USD | -86.222% |
| Surrozen, Inc. | -43.04 Million USD | -560.36% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -218.581% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 50364.736% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -49852.9% |
| Autolus Therapeutics plc | -208.38 Million USD | -36.399% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -295.327% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1211.759% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -178.468% |
| GRI Bio, Inc. | -13.03 Million USD | -2080.195% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -6774.511% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -387.592% |
| INmune Bio, Inc. | -30 Million USD | -847.187% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -157.086% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -573.635% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1680.717% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3586.215% |
| Jaguar Health, Inc. | -41.3 Million USD | -588.213% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1699.508% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -376.22% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -774.964% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -2.936% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -19.479% |
| Verastem, Inc. | -87.36 Million USD | -225.331% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -76.174% |
| Histogen Inc. | -10.62 Million USD | -2576.132% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1889.479% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -363.78% |
| Surrozen, Inc. | -43.04 Million USD | -560.36% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1837.373% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5487.387% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -3301.09% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -88.127% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -480.942% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2628.355% |
| Kronos Bio, Inc. | -112.67 Million USD | -152.263% |
| Turnstone Biologics Corp. | -55.2 Million USD | -414.913% |
| Synaptogenix, Inc. | -6.03 Million USD | -4606.994% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1653.653% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -4151.788% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -264.307% |
| Exelixis, Inc. | 207.76 Million USD | 236.805% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -97.455% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 46.232% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -340.909% |
| ESSA Pharma Inc. | -26.58 Million USD | -969.251% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -7005.889% |
| Avid Bioservices, Inc. | -140.75 Million USD | -101.937% |
| Insmed Incorporated | -749.56 Million USD | 62.081% |
| MediWound Ltd. | -6.71 Million USD | -4132.162% |
| OmniAb, Inc. | -50.61 Million USD | -461.512% |
| Alector, Inc. | -130.39 Million USD | -117.984% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -149.931% |
| Zai Lab Limited | -334.62 Million USD | 15.058% |
| AlloVir, Inc. | -190.41 Million USD | -49.267% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 12.27% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -182.265% |
| Aura Biosciences, Inc. | -76.4 Million USD | -271.992% |
| Immunic, Inc. | -93.61 Million USD | -203.628% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -109.159% |
| Veracyte, Inc. | -74.4 Million USD | -282.012% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3603.083% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -983.532% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 498.028% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3959.361% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1409.248% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1160.173% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 676.875% |
| Fortrea Holdings Inc. | -3.4 Million USD | -8259.765% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -124.434% |
| XBiotech Inc. | -24.55 Million USD | -1057.438% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -340.909% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -85.782% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -661.2% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -353.465% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -188.777% |
| Agenus Inc. | -245.76 Million USD | -15.654% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1226.513% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -414.978% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 53.146% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -316.427% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -25.467% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1176.442% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -114.526% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -5276.488% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1073.494% |
| Lantern Pharma Inc. | -15.96 Million USD | -1680.731% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -604.836% |
| Ainos, Inc. | -13.77 Million USD | -1964.057% |
| Pluri Inc. | -20.88 Million USD | -1260.743% |
| Prothena Corporation plc | -147.02 Million USD | -93.318% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -149.609% |
| Rallybio Corporation | -74.56 Million USD | -281.192% |
| Kodiak Sciences Inc. | -260.49 Million USD | -9.114% |
| Cue Biopharma, Inc. | -50.73 Million USD | -460.251% |
| MeiraGTx Holdings plc | -84.02 Million USD | -238.263% |
| Annexon, Inc. | -134.23 Million USD | -111.739% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -364.219% |
| Moderna, Inc. | -4.71 Billion USD | 93.97% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1480.472% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1139.51% |
| Blueprint Medicines Corporation | -506.98 Million USD | 43.937% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1742.546% |
| CalciMedica, Inc. | -34.35 Million USD | -727.29% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -109.995% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -71.442% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -394.205% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -0.345% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -707.592% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -171.03% |
| Nutriband Inc. | -5.48 Million USD | -5081.691% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -603.196% |
| Vor Biopharma Inc. | -117.86 Million USD | -141.155% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 106.536% |
| Alkermes plc | 355.75 Million USD | 179.895% |
| ProKidney Corp. | -35.46 Million USD | -701.376% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -137.329% |
| Arcellx, Inc. | -70.69 Million USD | -302.082% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 55.81% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -179.36% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -592.135% |
| Atai Life Sciences N.V. | -40.22 Million USD | -606.623% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -252.426% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -276.362% |
| MediciNova, Inc. | -8.57 Million USD | -3216.006% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -130.564% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3293.072% |
| GeoVax Labs, Inc. | -25.96 Million USD | -994.599% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -18.807% |
| Biomea Fusion, Inc. | -117.25 Million USD | -142.405% |
| RenovoRx, Inc. | -10.23 Million USD | -2677.873% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -85.576% |
| Geron Corporation | -184.12 Million USD | -54.367% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -842.726% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -181.873% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -20.469% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2118.12% |
| Royalty Pharma plc | 1.13 Billion USD | 125.046% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -47.299% |
| Imunon, Inc. | -19.51 Million USD | -1356.481% |
| BioAtla, Inc. | -123.46 Million USD | -130.218% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 13.149% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -669.255% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -65.569% |
| Structure Therapeutics Inc. | -89.62 Million USD | -217.152% |
| 89bio, Inc. | -142.18 Million USD | -99.897% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -179.014% |
| aTyr Pharma, Inc. | -50.38 Million USD | -464.075% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -224.173% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -19.559% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3412.532% |
| Akari Therapeutics, Plc | -10 Million USD | -2740.048% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -422078.983% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 200.937% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -60.475% |
| Liquidia Corporation | -78.5 Million USD | -262.07% |
| Entera Bio Ltd. | -8.88 Million USD | -3097.57% |
| GH Research PLC | -35.58 Million USD | -698.696% |
| Vericel Corporation | -3.18 Million USD | -8832.495% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -290.166% |
| Xencor, Inc. | -126.08 Million USD | -125.425% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -7447.915% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1680.717% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1236.522% |
| Vaxcyte, Inc. | -402.26 Million USD | 29.342% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -55.835% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 11428.497% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4164.611% |
| Portage Biotech Inc. | -75.33 Million USD | -277.271% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3293.072% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -194.069% |
| OncoCyte Corporation | -27.78 Million USD | -923.117% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2018.413% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2455.694% |
| Purple Biotech Ltd. | -19.88 Million USD | -1329.738% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -863.792% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -943.513% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -53.907% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3949.466% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -854.792% |
| United Therapeutics Corporation | 984.8 Million USD | 128.862% |
| HilleVax, Inc. | -123.56 Million USD | -130.024% |
| Silo Pharma, Inc. | -3.7 Million USD | -7580.528% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2074.38% |
| Pharming Group N.V. | -10.54 Million USD | -2594.653% |
| Tharimmune, Inc. | -9.31 Million USD | -2949.996% |
| Genprex, Inc. | -30.86 Million USD | -821.023% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -238.432% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -20.476% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -285.19% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -15850.168% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -5266.903% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1689197.053% |
| Savara Inc. | -54.69 Million USD | -419.639% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1300.779% |
| Curis, Inc. | -47.41 Million USD | -499.481% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1740.275% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -853.319% |
| BeiGene, Ltd. | -881.7 Million USD | 67.763% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -259.992% |
| Erasca, Inc. | -125.04 Million USD | -127.309% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5584.075% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5584.075% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -607.802% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4891.781% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -370.676% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -100.972% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -47.722% |
| Adicet Bio, Inc. | -142.65 Million USD | -99.24% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -87.508% |
| Aditxt, Inc. | -32.38 Million USD | -777.778% |
| Adagene Inc. | -18.94 Million USD | -1400.192% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3787.346% |
| Quantum-Si incorporated | -95.96 Million USD | -196.198% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1849.764% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 314.79% |
| Compugen Ltd. | -18.75 Million USD | -1415.581% |
| Generation Bio Co. | -126.61 Million USD | -124.491% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -289.941% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -244.766% |
| Invivyd, Inc. | -198.64 Million USD | -43.087% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 16.885% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -3172.084% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1346.304% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2778.59% |
| 2seventy bio, Inc. | -217.57 Million USD | -30.639% |
| Instil Bio, Inc. | -156.08 Million USD | -82.098% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1175.295% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -6507.715% |
| GeoVax Labs, Inc. | -25.96 Million USD | -994.599% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -773.407% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -187.708% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -76.756% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 53.788% |
| Evaxion Biotech A/S | -22.12 Million USD | -1184.664% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -252.051% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -42.068% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -311.132% |
| Cingulate Inc. | -23.53 Million USD | -1107.702% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -4012.153% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -613.076% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -377.677% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2277.51% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -310.758% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -11206770.039% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -230.906% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 23.927% |
| ImmunityBio, Inc. | -583.19 Million USD | 51.263% |
| Korro Bio, Inc. | -81.17 Million USD | -250.16% |
| Kineta, Inc. | -14.09 Million USD | -1915.973% |
| BioVie Inc. | -32.12 Million USD | -784.892% |
| Codexis, Inc. | -76.24 Million USD | -272.812% |
| Celularity Inc. | -196.29 Million USD | -44.798% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1706.712% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -32.491% |
| Virax Biolabs Group Limited | -6.73 Million USD | -4121.14% |
| Cibus, Inc. | -267.62 Million USD | -6.205% |
| IN8bio, Inc. | -30 Million USD | -847.219% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -142.591% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -801.065% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 22.402% |
| Eyenovia, Inc. | -27.26 Million USD | -942.629% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1416.437% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -53027.477% |
| Elevation Oncology, Inc. | -45.7 Million USD | -521.897% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -272.012% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -585.871% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -112.405% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -846.273% |
| Moolec Science SA | -51.78 Million USD | -448.828% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -442.728% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -577.162% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -109.062% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -568.876% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -3096.562% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1237.989% |
| Humacyte, Inc. | -110.77 Million USD | -156.583% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -312.169% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2639.058% |
| Genelux Corporation | -28.29 Million USD | -904.46% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -877.918% |
| Notable Labs, Ltd. | -11.26 Million USD | -2423.366% |
| Immunovant, Inc. | -259.33 Million USD | -9.6% |
| Quantum-Si incorporated | -95.96 Million USD | -196.198% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1366.55% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -196.106% |
| Acasti Pharma Inc. | -12.85 Million USD | -2111.406% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1165.624% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -629.024% |
| PepGen Inc. | -78.62 Million USD | -261.499% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1176.873% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5832.047% |
| Immuneering Corporation | -53.47 Million USD | -431.557% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5487.387% |
| Belite Bio, Inc | -31.63 Million USD | -798.558% |
| XOMA Corporation | -40.83 Million USD | -596.118% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -422.822% |
| Bionomics Limited | -15.49 Billion USD | 98.165% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -874.833% |
| uniQure N.V. | -308.47 Million USD | 7.86% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3787.346% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -130.278% |
| Forte Biosciences, Inc. | -31.47 Million USD | -803.012% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3365.524% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -877.818% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -53027.477% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -983.532% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1624.186% |
| Altimmune, Inc. | -88.44 Million USD | -221.359% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -128.022% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -874.833% |
| Peak Bio, Inc. | -1259.26 USD | -22571251.429% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -517.238% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1206.754% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 16.104% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -242.638% |
| Zura Bio Limited | -60.36 Million USD | -370.895% |
| PolyPid Ltd. | -23.86 Million USD | -1090.999% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -242.638% |
| argenx SE | -295.05 Million USD | 3.667% |
| Immunome, Inc. | -106.8 Million USD | -166.12% |
| Verona Pharma plc | -54.36 Million USD | -422.783% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -184.468% |
| Shattuck Labs, Inc. | -87.29 Million USD | -225.588% |
| CervoMed Inc. | -2.17 Million USD | -12986.953% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2034.515% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -552.582% |
| Moolec Science SA | -51.78 Million USD | -448.828% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1643645.305% |
| Design Therapeutics, Inc. | -66.86 Million USD | -325.102% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -249.119% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -650.309% |
| Achilles Therapeutics plc | -69.66 Million USD | -307.998% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -11206770.039% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -484.755% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -268.697% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -736.715% |
| MoonLake Immunotherapeutics | -36 Million USD | -689.374% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -574.751% |
| Beam Therapeutics Inc. | -132.52 Million USD | -114.471% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -73.933% |
| AEON Biopharma, Inc. | -52.55 Million USD | -440.817% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -332.193% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -297.061% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2171.331% |
| NeurAxis, Inc. | -14.62 Million USD | -1843.243% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 35.989% |
| Lumos Pharma, Inc. | -34.03 Million USD | -735.141% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 9546.721% |
| Palisade Bio, Inc. | -12.3 Million USD | -2210.829% |
| Nutriband Inc. | -5.48 Million USD | -5081.691% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -154.766% |
| Neurogene Inc. | -36.31 Million USD | -682.642% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3243.513% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -189.598% |
| Athira Pharma, Inc. | -117.67 Million USD | -141.546% |
| HCW Biologics Inc. | -24.99 Million USD | -1037.188% |
| XOMA Corporation | -40.83 Million USD | -596.118% |
| Nektar Therapeutics | -276.05 Million USD | -2.962% |
| Arvinas, Inc. | -367.3 Million USD | 22.616% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -422078.983% |
| Merus N.V. | -154.93 Million USD | -83.448% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -191.735% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -805.63% |
| Rezolute, Inc. | -68.45 Million USD | -315.186% |
| Clene Inc. | -49.5 Million USD | -474.16% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1742.854% |
| BeyondSpring Inc. | -21.02 Million USD | -1251.812% |
| Synlogic, Inc. | -57.28 Million USD | -396.198% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2288.304% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2525.457% |
| Peak Bio, Inc. | -1259.26 USD | -22571251.429% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -660.629% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2700.0% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -98.626% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 12.572% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -6053.586% |
| MannKind Corporation | -11.93 Million USD | -2280.901% |
| Ikena Oncology, Inc. | -68.16 Million USD | -316.97% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1252.52% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -205.846% |
| Gossamer Bio, Inc. | -179.81 Million USD | -58.067% |
| CohBar, Inc. | -11.96 Million USD | -2276.101% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1002.187% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -842.726% |
| Legend Biotech Corporation | -518.25 Million USD | 45.156% |
| Mural Oncology plc | -207.44 Million USD | -37.014% |
| Disc Medicine, Inc. | -76.42 Million USD | -271.89% |
| Champions Oncology, Inc. | -7.27 Million USD | -3806.432% |
| REGENXBIO Inc. | -263.49 Million USD | -7.87% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2578.131% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -498.32% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -648.304% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -183.769% |
| Vaxart, Inc. | -82.46 Million USD | -244.67% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 85259.829% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -657.094% |
| Cellectis S.A. | -101.05 Million USD | -181.254% |
| Longeveron Inc. | -21.41 Million USD | -1227.381% |
| Repare Therapeutics Inc. | -93.79 Million USD | -203.032% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 46.969% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -299.376% |
| Revolution Medicines, Inc. | -436.36 Million USD | 34.864% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -4225.552% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -822.113% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -309.952% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -339.09% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2797.075% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 107.853% |
| Denali Therapeutics Inc. | -145.22 Million USD | -95.72% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -236259.705% |
| Veru Inc. | -93.15 Million USD | -205.125% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -951.582% |
| Cingulate Inc. | -23.53 Million USD | -1107.702% |
| Passage Bio, Inc. | -102.06 Million USD | -178.49% |
| Context Therapeutics Inc. | -23.96 Million USD | -1086.069% |
| Exicure, Inc. | -16.91 Million USD | -1580.454% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -50.453% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -652.653% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -4267.878% |
| Nuvalent, Inc. | -126.21 Million USD | -125.19% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2602.941% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -227.158% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -830.566% |
| OmniAb, Inc. | -50.61 Million USD | -461.512% |
| Anew Medical, Inc. | 1.34 Million USD | 21214.83% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1671.468% |
| Lipocine Inc. | -16.35 Million USD | -1638.201% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -328.099% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -346.379% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -573.635% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -492.557% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1333.271% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 47.509% |
| Ocugen, Inc. | -63.07 Million USD | -350.604% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -196.904% |
| Q32 Bio Inc. | -112.96 Million USD | -151.62% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1553.281% |
| Alumis Inc. Common Stock | -154.99 Million USD | -83.384% |
| Equillium, Inc. | -13.33 Million USD | -2031.474% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -370.848% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3458.31% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1407.764% |
| Dominari Holdings Inc. | -22.88 Million USD | -1142.164% |
| Edesa Biotech, Inc. | -8.37 Million USD | -3294.052% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1303.615% |
| Bio-Techne Corporation | 168.1 Million USD | 269.08% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 19.272% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 320.586% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -133.298% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -649.182% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -152.332% |
| Nkarta, Inc. | -117.5 Million USD | -141.898% |
| BioCardia, Inc. | -11.57 Million USD | -2356.417% |
| Iterum Therapeutics plc | -38.37 Million USD | -640.747% |